EcoDrugPlus

Bcl-2-Like Protein 1

Ensembl ID : ENSONIG00000020298
Gene Symbol: LOC100700270
2 Cross references
219 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSONIG00000016675
Gene Symbol: BACE1
4 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000001433
Gene Symbol: BDKRB2
1 Cross references
223 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000030376
Gene Symbol: BDKRB2
1 Cross references
228 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000039341
Gene Symbol: BDKRB2
1 Cross references
228 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000020742
Gene Symbol: BDKRB2
1 Cross references
146 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000001435
Gene Symbol: BDKRB2
1 Cross references
167 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000032381
Gene Symbol: BDKRB2
1 Cross references
222 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000020741
Gene Symbol: BDKRB2
1 Cross references
228 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSONIG00000032096
Gene Symbol: BDKRB2
1 Cross references
226 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c

Ensembl ID : ENSONIG00000003869
Gene Symbol: LOC100697375
3 Cross references
193 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSONIG00000007200
Gene Symbol: CACNA1DA
1 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).